> top > docs > PMC:7461420 > spans > 30622-30870 > annotations

PMC:7461420 / 30622-30870 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T165 10-26 Body_part denotes Neurotransmitter http://purl.org/sig/ont/fma/fma302832
T166 48-56 Body_part denotes clathrin http://purl.org/sig/ont/fma/fma62262
T167 133-139 Body_part denotes serine http://purl.org/sig/ont/fma/fma82764

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T175 191-195 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T344 169-171 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T345 189-190 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T346 230-238 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T270 27-37 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T271 133-158 Chemical denotes serine protease inhibitor http://purl.obolibrary.org/obo/CHEBI_64926
T272 133-139 Chemical denotes serine http://purl.obolibrary.org/obo/CHEBI_17822
T273 140-158 Chemical denotes protease inhibitor http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T275 149-158 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T276 159-167 Chemical denotes camostat http://purl.obolibrary.org/obo/CHEBI_135632
T277 202-211 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
978 222-229 Gene denotes TMPRSS2 Gene:7113
980 191-199 Species denotes SARS‐CoV Tax:694009
982 133-139 Chemical denotes serine MESH:D012694

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T286 0-248 Sentence denotes Figure 7 Neurotransmitter inhibitors targeting clathrin/nonclathrin pathways Matsuyama et al. identified the commercially available serine protease inhibitor camostat (18; Figure 8) to be a SARS‐CoV‐1 inhibitor, blocking TMPRSS2 activity at 10 µM.